Association rule mining of clinical and biomarker data in neuroendocrine tumors: A prospective study on disease progression
Journal of Neuroendocrinology · 2025-10 · 37 (10)
DOI: 10.1111/jne.70069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 14.08.2025. Verfasst von Ulrich Peter Knigge und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Transplantation, ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Biomarkers, Tumor, Data Mining, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ipsen.
Abstract (Originalsprache)
There is an unmet need for new methods to predict disease course in patients with neuroendocrine tumors (NET). We investigated 92 putative cancer‐related plasma proteins including chromogranin A (CgA) and clinical parameters at the time of diagnosis to identify early factors associated with progressive (PD) or stable disease (SD). Patients with NET grade 1 and 2 of the small intestine (siNET) and pancreas (pNET) were included in this prospective study. Blood samples were obtained at the time of diagnosis before tumor‐related therapy was initiated. During 3 years of follow‐up, SD or PD was determined according to current clinical practice by each investigator. Association rule mining (ARM) was used to identify combinations of biomarkers and clinical parameters associated with SD or PD. Altogether, 115 patients with siNET and 30 with pNET with complete clinical and biomarker data were included in the analysis representing 3 years of follow‐up. Several novel plasma proteins and clinical factors were associated with either PD or SD. In siNET, CgA (>4 upper limits of normal [ULN]) was the most frequent biomarker associated with PD. Females, in contrast to males, with CgA >4 ULN showed a high risk of progression (PPV 100%, NPV 63%). In the siNET cohort, Carboxypeptidase E (CPE) was a discriminating factor between SD and PD. CPE 3.14 was associated with PD ( p = 0.003). In the pNET cohort, among clinical variables, only the presence of liver metastasis was associated with PD. CgA was not among the top biomarkers associated with PD. Several parameters, both clinical and biomarker data, as well as combinations of these, were associated with PD or SD 3 years after diagnosis. We identified novel biomarkers improving the association with PD or SD. [Correction added on 28 August 2025, after first online publication: Abstract has been updated.]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery and Transplantation, ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Nephrology and Endocrinology, ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital Solna, Stockholm, Sweden.
- Department of Hepatology and Gastroenterology, Aarhus University Hospital, ENETS Center of Excellence, Aarhus, Denmark.
- Department of Gastroenterology, Oslo University Hospital, Rikshospitalet, ENETS Center of Excellence, Oslo, Norway.
- Endocrinology, Abdominal Center, Helsinki University Hospital and University of Helsinki, ENDO-ERN (European Reference Network on Rare Endocrine Conditions), Helsinki, Finland.
ORCID-Profile: Henning Grønbæk, Espen Thiis-Evensen, Camilla Schalin-Jäntti, Halfdan Sørbye, Maria Del Pilar Schneider, Roger Belusa
Förderung
- Ipsen
Zitieren
APA
Knigge, U. P., Kjellman, M., Grønbæk, H., Thiis-Evensen, E., Schalin-Jäntti, C., Welin, S., Sørbye, H., Schneider, M. D. P., Belusa, R., & Nordic NET Biomarker Group (2025). Association rule mining of clinical and biomarker data in neuroendocrine tumors: A prospective study on disease progression. Journal of Neuroendocrinology, 37(10). https://doi.org/10.1111/jne.70069
Vancouver
Knigge UP, Kjellman M, Grønbæk H, Thiis-Evensen E, Schalin-Jäntti C, Welin S, et al. Association rule mining of clinical and biomarker data in neuroendocrine tumors: A prospective study on disease progression. Journal of Neuroendocrinology. 2025;37(10). doi:10.1111/jne.70069
BibTeX
@article{Knigge2025,
author = {Knigge, Ulrich Peter and Kjellman, Magnus and Grønbæk, Henning and Thiis-Evensen, Espen and Schalin-Jäntti, Camilla and Welin, Staffan and Sørbye, Halfdan and Schneider, Maria Del Pilar and Belusa, Roger and Nordic NET Biomarker Group, Nordic NET Biomarker Group},
title = {Association rule mining of clinical and biomarker data in neuroendocrine tumors: A prospective study on disease progression},
journal = {Journal of Neuroendocrinology},
year = {2025},
volume = {37},
number = {10},
doi = {10.1111/jne.70069}
}
EUVIMED